Ltr Pharma Fpo has released a press release.
Response to ASX Query Letter
Filed with ASX ·
6ix hasn’t read this filing yet.
Later from LTR Pharma
- SPONTAN Achieves Key Manufacturing Validation
- Recruitment commences for SPONTAN Clinical Study
- First patients dosed in SPONTAN pivotal study
- Final Patients dosed in SPONTAN pivotal study
- Response to ASX Price Query
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma